Paper-Based Microneedle Skin Patch for Continuous Glucose Monitoring
|
By LabMedica International staff writers Posted on 23 Sep 2020 |

Image: Illustration demonstrating painless and biodegradable microneedles on a paper patch (Photo courtesy of University of Tokyo)
A microneedle skin patch for the continuous monitoring of an individual’s glucose level was designed to be a painless and disposable screening and diagnostic test for diabetes patients, as well as those with pre-diabetes.
Porous microneedles are expected to have a variety of potential applications in diagnostics owing to their ability to penetrate human skin painlessly and extract bio‐fluid by capillary action. Investigators at the University of Tokyo (Japan) have applied this technology for screening and monitoring levels of glucose.
The microneedles were fabricated by pouring a mixture of a melted biodegradable polymer and salt into the cone-shaped cavities of a micro-mold while applying heat. The mold was then inverted with the needles on the lower side, and the device was placed on top of a sheet of paper with high pressure applied from above. The high pressure forced the polymer mixture into the pores of the paper, securing the attachment and allowing fluid drawn through the needles to pass effortlessly into the paper. After removal from the mold, the needles were cooled in a solution that removed the salt, leaving behind pores, through which fluid could flow into the paper. A paper glucose sensor was then attached to the paper base of the needle array. The final product was disposable and biodegradable, and its use did not require any medical expertise or training.
The paper‐based glucose sensor was used to demonstrate the absorption property of the microneedles, and showed successful sample extraction and glucose concentration analysis from agarose gel‐based skin mimics. The investigators maintained that the platform had the potential to integrate various different paper‐based bio‐sensors in order to function as painless and disposable rapid screening and diagnostic tests for many metabolites.
"We have overcome this problem by developing a way to combine porous microneedles with paper-based sensors," said senior author Dr. Beomjoon Kim, professor in the institute of industrial science at the University of Tokyo. "The result is low-cost, disposable, and does not require any additional instruments."
The microneedle device was described in the August 2020 issue of the journal Medical Devices & Sensors.
Related Links:
University of Tokyo
Porous microneedles are expected to have a variety of potential applications in diagnostics owing to their ability to penetrate human skin painlessly and extract bio‐fluid by capillary action. Investigators at the University of Tokyo (Japan) have applied this technology for screening and monitoring levels of glucose.
The microneedles were fabricated by pouring a mixture of a melted biodegradable polymer and salt into the cone-shaped cavities of a micro-mold while applying heat. The mold was then inverted with the needles on the lower side, and the device was placed on top of a sheet of paper with high pressure applied from above. The high pressure forced the polymer mixture into the pores of the paper, securing the attachment and allowing fluid drawn through the needles to pass effortlessly into the paper. After removal from the mold, the needles were cooled in a solution that removed the salt, leaving behind pores, through which fluid could flow into the paper. A paper glucose sensor was then attached to the paper base of the needle array. The final product was disposable and biodegradable, and its use did not require any medical expertise or training.
The paper‐based glucose sensor was used to demonstrate the absorption property of the microneedles, and showed successful sample extraction and glucose concentration analysis from agarose gel‐based skin mimics. The investigators maintained that the platform had the potential to integrate various different paper‐based bio‐sensors in order to function as painless and disposable rapid screening and diagnostic tests for many metabolites.
"We have overcome this problem by developing a way to combine porous microneedles with paper-based sensors," said senior author Dr. Beomjoon Kim, professor in the institute of industrial science at the University of Tokyo. "The result is low-cost, disposable, and does not require any additional instruments."
The microneedle device was described in the August 2020 issue of the journal Medical Devices & Sensors.
Related Links:
University of Tokyo
Latest Technology News
- Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
- Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detection
- New Automation Workflow Streamlines NGS Library Preparation for High-Volume Labs
- ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine
- Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions
- New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling
- Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins
- Autonomous Robotic System Receives FDA Authorization for Blood Collection
- Interoperable Data Platform Standardizes Multi-Cancer Blood Test Results
- Training Device Improves Accuracy of Pooled Molecular Diagnostics
- New CE-Certified Software Advances Whole-Genome Cancer Testing
- National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
Channels
Clinical Chemistry
view channel
Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome
Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more
Study Questions Broad Fasting Requirements Before Routine Blood Tests
Routine blood testing is central to diagnosis, monitoring, and disease risk assessment. Many patients are still asked to fast for 8–12 hours before phlebotomy, even though the requirement was originally... Read more
Elevated Lipoprotein(a) Linked to Long-Term Progression of Carotid Atherosclerosis
Lipoprotein(a), or Lp(a), is a genetically determined blood lipid and an important risk factor for cardiovascular disease. Its relationship to long-term carotid atherosclerosis has remained unclear, particularly... Read moreHematology
view channel
New Donor Genetic Marker May Help Predict Stem Cell Transplant Success
Donor selection for hematopoietic stem cell transplantation plays a major role in relapse risk and survival for patients with blood cancers and other blood disorders. Despite advances in genotyping, uncertainty... Read more
Updated Ferritin Thresholds Improve Detection of Iron Deficiency
Iron deficiency is one of the most common health conditions worldwide, yet its nonspecific symptoms can delay diagnosis for months. Variation in testing practices and ferritin thresholds may contribute... Read moreImmunology
view channel
Single-Tier Lyme Disease Test Shows High Sensitivity in Early Infection
Lyme disease can be difficult to diagnose during the earliest stages of infection, when conventional serologic testing may have limited sensitivity. Patients may present during a diagnostic gray zone in... Read more
New Web-Based Platform Helps Autoimmune Laboratories Manage Testing Complexity
Autoimmune disease testing often requires laboratories to coordinate results across multiple instruments, manual microscopy, and patient histories. As testing volumes and workflow complexity increase,... Read moreMicrobiology
view channel
Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis
Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more
Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification
Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more
Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive
Fungal bloodstream infections pose a major threat to hospitalized patients. Candida species cause most invasive fungal infections worldwide and are among the leading causes of hospital-acquired bloodstream... Read more
FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample
Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read morePathology
view channel
Rapid Mass Spectrometry Test May Aid Glioma Margin Decisions
Glioma brain tumors are highly infiltrative and can extend into nearby healthy brain tissue, making tumor margins difficult to define during surgery. Residual tumor cells may contribute to recurrence and... Read more
Genomic Classifier Predicts Benefit From Adding Hormone Therapy to Salvage Prostate Radiation
Men who have undergone prostatectomy for prostate cancer may later develop a detectable or rising prostate-specific antigen, prompting salvage radiation therapy. A key challenge is determining who is most... Read moreTechnology
view channelLaser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more
Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detection
Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer-related death worldwide. Early detection remains critical, but cancer biomarkers can produce only faint... Read moreIndustry
view channel
Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China
Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Collaboration Advances Automated Benchtop Platform for Routine Blood Testing
Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Expanded Partnership Supports AI Biomarker Validation and Clinical Trial Deployment
CellCarta (Montreal, Canada) and Imagene AI (Miami, FL, USA) have expanded their collaboration to provide biopharma companies with a coordinated pathway for biomarker strategy, assay development, validation,... Read more







